rs67507747
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000088.4(COL1A1):c.1678G>T(p.Gly560Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 11/19 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G560R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000088.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL1A1 | NM_000088.4 | c.1678G>T | p.Gly560Cys | missense_variant | 25/51 | ENST00000225964.10 | NP_000079.2 | |
COL1A1 | XM_011524341.2 | c.1480G>T | p.Gly494Cys | missense_variant | 22/48 | XP_011522643.1 | ||
COL1A1 | XM_005257058.5 | c.1678G>T | p.Gly560Cys | missense_variant | 25/49 | XP_005257115.2 | ||
COL1A1 | XM_005257059.5 | c.958-1339G>T | intron_variant | XP_005257116.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL1A1 | ENST00000225964.10 | c.1678G>T | p.Gly560Cys | missense_variant | 25/51 | 1 | NM_000088.4 | ENSP00000225964.6 | ||
COL1A1 | ENST00000463440.1 | n.68G>T | non_coding_transcript_exon_variant | 3/3 | 2 | |||||
COL1A1 | ENST00000471344.1 | n.710G>T | non_coding_transcript_exon_variant | 8/8 | 2 | |||||
COL1A1 | ENST00000476387.1 | n.27G>T | non_coding_transcript_exon_variant | 1/9 | 2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Osteogenesis imperfecta type I Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 26, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 30, 2022 | ClinVar contains an entry for this variant (Variation ID: 526860). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly560 amino acid residue in COL1A1. Other variant(s) that disrupt this residue have been observed in individuals with COL1A1-related conditions (PMID: 8799376, 17078022, 24668929, 27510842), which suggests that this may be a clinically significant amino acid residue. This variant disrupts the triple helix domain of COL1A1. Glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236). In COL1A1, variants affecting these glycine residues are significantly enriched in individuals with disease (PMID: 9016532, 17078022) compared to the general population (ExAC). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt COL1A1 protein function. This missense change has been observed in individual(s) with clinical features of osteogenesis imperfecta (PMID: 17078022, 28378289). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 560 of the COL1A1 protein (p.Gly560Cys). - |
COL1A1-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 27, 2022 | The COL1A1 c.1678G>T variant is predicted to result in the amino acid substitution p.Gly560Cys. This variant was reported in individuals with osteogenesis imperfecta (Bardai et al. 2017. PubMed ID: 28378289; Marini et al. 2007. PubMed ID: 17078022; https://databases.lovd.nl/shared/genes/COL1A1). Different missense variants altering the same amino acid residue (p.Gly560Ser, p.Gly560Arg) have also been reported in individuals with osteogenesis imperfecta (for examples see Marini et al. 2007. PubMed ID: 17078022). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 27, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at